Creditable Coverage, and How the Part D Late Enrollment Penalty Is Built

Answer first: a 63-day gap without creditable coverage is what triggers it

The penalty regulation states the trigger in one construction. A Part D eligible individual must pay the late penalty if there is "a continuous period of 63 days or longer at any time after the end of the individual's initial enrollment period" during which three things were all true at once: the individual was eligible to enroll in a Part D plan, was not covered under any creditable prescription drug coverage, and was not enrolled in a Part D plan.

All three conditions have to hold for the same stretch. Someone eligible but enrolled has no gap. Someone eligible and unenrolled but holding creditable coverage elsewhere has no gap either. The penalty is aimed only at the combination.

The statute says the same thing with a slightly different frame, counting a continuous period of 63 days or longer beginning the day after the last date of the individual's initial enrollment period and ending on the date of enrollment in a prescription drug plan or an MA-PD plan, during all of which the individual was not covered under any creditable prescription drug coverage.

Everything else in this area — what counts as creditable, who has to tell you, what the surcharge is, and who is exempt — sits underneath that one test.

What makes coverage 'creditable' is an actuarial comparison

The regulation defines creditable prescription drug coverage as coverage of a listed type "only if the actuarial value of the coverage equals or exceeds the actuarial value of defined standard prescription drug coverage under Part D in effect at the start of such plan year," leaving out of the comparison the value of the manufacturer discount and of any selected drug subsidy. That value can be demonstrated through generally accepted actuarial principles in accordance with CMS guidelines.

There is also a simplified route for group health plans that are not receiving a retiree drug subsidy. Under that methodology the coverage must provide reasonable coverage for brand name and generic prescription drugs and biological products, provide reasonable access to retail pharmacies, and be designed to pay on average a minimum percent of participants' prescription drug expenses — a percentage the regulation sets at 73 percent for 2027, with values for later years to be updated by CMS in subregulatory guidance.

The list of coverage types that can qualify is long and specific: a prescription drug plan or MA-PD plan; Medicaid coverage or coverage under a section 1115 waiver; a group health plan, including the Federal employees health benefits program and qualified retiree prescription drug plans, but excluding an account-based medical plan; State Pharmaceutical Assistance Programs; veterans', survivors' and dependents' drug coverage under title 38; a Medicare supplemental policy; military coverage including TRICARE; individual health insurance coverage that includes outpatient prescription drugs and is not an excepted benefit; Indian Health Service, Tribal or Urban Indian program coverage; PACE coverage; cost-based HMO or CMP coverage; a State high-risk pool; and other coverage the Secretary may determine appropriate.

Being on that list is necessary but not sufficient. The actuarial test in the definition applies on top of it.

The coverage provider has to tell you, in writing, at set times

This is the part of the rule people are least likely to know exists. Each entity offering one of the listed types of coverage — with an exception for Part D plans, MA-PD plans, PACE and cost-based plans that already provide qualified prescription drug coverage — "must disclose to all Part D eligible individuals enrolled in or seeking to enroll in the coverage whether the coverage is creditable prescription drug coverage."

When the coverage is not creditable, the disclosure must go further. It must state that fact as provided by CMS, state that there are limitations on the periods in a year in which the individual may enroll in Part D plans, and state that the individual may be subject to a late enrollment penalty.

The timing is specified rather than left to the plan. Notices must be provided at minimum before an individual's initial enrollment period for Part D, before the effective date of enrollment in the coverage and upon any change that affects whether the coverage is creditable, before the annual coordinated election period begins, and upon request by the individual. The same entities must also disclose creditable status to CMS in the form and manner CMS describes.

There is a remedy attached to a failure to inform. If an individual establishes to CMS that they were not adequately informed that their coverage was not creditable, the individual "may apply to CMS to have the coverage treated as creditable prescription drug coverage" for purposes of applying the penalty. That is an application, not an entitlement, and the regulation describes it as such.

What the surcharge is, and who does not pay it

The premium regulation states the amount. For a continuous period of eligibility, the penalty is the greater of an amount CMS determines is actuarially sound for each uncovered month, or "1 percent of the base beneficiary premium" for each uncovered month in the period. The statute states the same two-branch test, and defines an uncovered month as any month beginning after the end of the initial enrollment period unless the individual can demonstrate creditable prescription drug coverage for any portion of that month.

Two features of that definition matter. The unit is the month, not the year, so each additional uncovered month adds an increment. And coverage for any portion of a month is enough to keep that month from counting — the demonstration burden, as the statute writes it, sits with the individual.

The base beneficiary premium the one percent attaches to is itself a computed national figure. The regulation defines it as the product of a beneficiary premium percentage and the national average monthly bid amount, with the percentage for the years 2024 through 2029 set as the lesser of the prior year's percentage increased by 6 percent or the percentage produced by the general formula. Because that figure is recalculated each year, so is the dollar value of a penalty.

There is one clean exemption. The premium subsidy regulation states that subsidy eligible individuals "are not subject to a late enrollment penalty." People who qualify for the low-income subsidy are outside the penalty rule entirely, not merely helped with it.

Plans are also given a role in the mechanics. Part D sponsors must obtain information on prior creditable coverage from all enrolled or enrolling beneficiaries and report it to CMS in the form and manner CMS determines, and they must retain the information collected about a creditable coverage period determination under the enrollment record retention requirements.

Reconsideration, and the enrollment windows that surround the rule

Someone determined to be subject to the penalty may request reconsideration of that determination, consistent with the disclosure regulation. The review is conducted by CMS or by an independent review entity contracted by CMS, in accordance with CMS guidance. The regulation then adds a limit that is easy to miss: "Decisions made through this review are not subject to appeal, but may be reviewed and revised at the discretion of CMS." This is a reconsideration channel, and it is not the multi-level appeals process that governs coverage denials.

The enrollment periods themselves frame when a gap can open and close. For someone first eligible on or after March 2006, the Part D initial enrollment period is generally the same as the initial enrollment period for Part B, with stated exceptions for people not eligible to enroll in a Part D plan during that Part B window and for people whose Medicare entitlement is established retroactively. Since 2011, the annual coordinated election period for the following calendar year runs October 15 through December 7.

The regulation also provides special enrollment periods that connect directly to creditable coverage. One applies where the individual involuntarily loses creditable prescription drug coverage, or that coverage is involuntarily reduced so that it is no longer creditable — and the same provision states that a loss caused by failure to pay a required premium is not treated as an involuntary loss. Another applies where the individual was not adequately informed that they had lost creditable coverage, never had it, or that it had been reduced below creditable; that one requires CMS approval before use and a CMS-operated election mechanism.

Put together, the design is consistent. A person who keeps coverage that meets the actuarial test accumulates no uncovered months. A person who loses that coverage involuntarily gets a window to move without a gap. A person who was never told their coverage failed the test has a route to ask for relief. Whether any of those apply to a given record is decided on that record.